Antibodies and peptides for detection of plasmodium vivax
CA 2372213 A1 · Owner: Carrigan, Michelle C. · Inventors: Carrigan, Michelle C.; Mallonee, Richard L.; Baggett, David W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel peptides comprising an amino acid sequence which is repeated in the <i>P. vivax</i> ESP-1 protein (PvESP-1) are disclosed. Also disclosed are antibodies generated in response to immunization with these peptides which exhibit high specificity and sensitivity for <i>P. vivax</i> antigens in diagnostic assays. Assay methods employing the inventive antibodies and kits for carrying out the inventive methods are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 8, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 8, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 8, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.